🔴 $CYTK — Malik Fady Ibraham, EVP Research & Development
SOLD: 3,500 shares @ $61.38
Total: $215K
Filed Oct 5, 2026 · 8:00pm ET
📈 History & trend → https://www.formdelta.com/ticker/CYTK

#InsiderTrading #CYTK #StockMarket

🔴 $CYTK — Malik Fady Ibraham, EVP Research & Development
SOLD: 3,500 shares @ $68.29
Total: $239K
Filed Sep 21, 2026 · 8:00pm ET
📈 History & trend → https://www.formdelta.com/ticker/CYTK

#InsiderTrading #CYTK #StockMarket

📋 Today's Insider Activity — 4 filings

$ARCB — Parks Jason T, VP - Controller(1) (SELL, $116K)
$VIRC — VIRTUE DOUGLAS A, Executive Vice President (BUY, $18K)
$HFWA — Rivera Frederick B, Director (SELL, $37K)
$CYTK — Landry Robert E, Director (SELL, $72K)

📈 Search any ticker → https://www.formdel

📄 $CYTK 10-Q — what changed
MD&A now says: "In July 2026, the Medicines and Healthcare products Regulatory Agency (MHRA) granted MYQORZO marketing authorization across the United Kingdom for the treatment of symptomatic oHCM in adult patients."
📈 Full redline → https://www.formdelta.com/ticker/CYT

🔴 $CYTK — Blum Robert I, President & CEO
SOLD: 97,926 shares @ $69.33
Total: $6.8M
Filed Sep 13, 2026 · 8:00pm ET
📈 History & trend → https://www.formdelta.com/ticker/CYTK

#InsiderTrading #CYTK #StockMarket

🔴 $CYTK — Blum Robert I, President & CEO
SOLD: 7,500 shares @ $73.44
Total: $551K
Filed Sep 13, 2026 · 8:00pm ET
📈 History & trend → https://www.formdelta.com/ticker/CYTK

#InsiderTrading #CYTK #StockMarket